//assets.cakeresume.com/assets/contentarea/contentarea-2d64eca8dae2a1ffb31e0fb1df887bbad072c7c19734d7d30fa14884bbcc299a.css

Amiel Gross currently serves as Head of Legal at the Center for Breakthrough Medicines in Philadelphia, focusing on building and managing their legal function. He is responsible for ensuring the business strategies and policies are aligned with all risks taken into consideration. Counseling executives and senior management, negotiating complex commercial transactions, facilitating strategic alliances, supporting a range of legal issues arising during highly-regulated biotechnology business operations - these topics highlight his work as an attorney who specializes in cell & gene therapy manufacturing.

This professional oversight responsibility and hands-on experience across array of subject matters. These subjects include licensing deals, master services agreements, procurement contracts, intellectual property, corporate affairs, sponsored R&D collaborations, FDA regulatory and compliance, litigation, labor and employment, cybersecurity and privacy.

Amiel Gross has studied International Law at the Queen Mary University of London. He holds a Bachelor of Arts Degree from the Southwestern University and a Doctor of Law Degree from The University of Texas School of Law.

His skills include general corporate counsel, life science industry, biotechnology, industry knowledge, pharmaceutical law, biopharmaceuticals, corporate law, licensing, regulatory compliance. He is also highly experienced at business transactions, commercial contracts, CDMO, CGT, cell and gene therapy.


The University of Texas School of Law

Southwestern University School of Law

Queen Mary University of London

Head of Legal

Amiel Gross

Center for Breakthrough Medicines

Amiel Gross serves as Head of Legal at the Center for Breakthrough Medicines at Philadelphia since 2020. He focuses on building and managing the legal function of a rapidly growing biotechnology company in cell and gene therapy manufacturing.

Managed internal legal matters for Discovery Labs, a life science real estate holding company, in connection with the spinoff of its core operating business, Center for Breakthrough Medicines, a biotech startup focused on outsourced end-to-end manufacturing of Cell & Gene Therapy drug products.

Discovery Labs

General Counsel

Senior Associate at Dentons, a global law firm driven to provide you with the competitive edge in an increasingly complex and interconnected marketplace.

Dentons

Senior Associate

Associate at Orrick, Herrington & Sutcliffe LLP, a global law firm focused on serving the technology & innovation, energy & infrastructure and finance sectors.

Amiel Gross’s posts